{"abstract": "They both cautioned that there was no assurance that an actual transaction would be signed as a result of these talks.", "web_url": "https://www.nytimes.com/2016/12/21/business/dealbook/johnson-johnson-and-actelion-confirm-merger-talks-are-back-on.html", "snippet": "They both cautioned that there was no assurance that an actual transaction would be signed as a result of these talks.", "lead_paragraph": "Johnson & Johnson has resumed acquisition talks with Actelion Pharmaceuticals, the $20 billion Swiss biopharmaceutical company, after announcing just last week that it was severing discussions over a deal.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Johnson & Johnson and Actelion Confirm Merger Talks Are Back On", "kicker": null, "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Actelion Pharmaceuticals Ltd", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Sanofi SA", "rank": 5, "major": "N"}], "pub_date": "2016-12-21T19:17:19+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Leslie Picker", "person": [{"firstname": "Leslie", "middlename": null, "lastname": "Picker", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/be2d4587-11be-5d36-973e-e73cc2ec83ca", "word_count": 261, "uri": "nyt://article/be2d4587-11be-5d36-973e-e73cc2ec83ca"}